126 related articles for article (PubMed ID: 31095528)
1. Combining fluorine-18 fluorodeoxyglucose positron emission tomography and pathological risk factors to predict postoperative recurrence in stage I lung adenocarcinoma.
Hsu CC; Ho KW; Chang YH; Huang YC
Nucl Med Commun; 2019 Jun; 40(6):632-638. PubMed ID: 31095528
[TBL] [Abstract][Full Text] [Related]
2. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
3. [The prognostic impact of preoperative PET-CT on postoperative recurrence for completely resected stage I non-small cell lung cancer].
Qiang G; Xu R; Liu J; Yan J; Xu Y; Di J; Da J; Liang C; Shi B; Guo Y; Liu D
Zhonghua Wai Ke Za Zhi; 2015 Jul; 53(7):502-7. PubMed ID: 26359072
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Mar; 143(3):607-12. PubMed ID: 22104678
[TBL] [Abstract][Full Text] [Related]
5. Utility of Maximum Standard Uptake Value as a Predictor for Differentiating the Invasiveness of T1 Stage Pulmonary Adenocarcinoma.
Fu L; Alam MS; Ren Y; Guan W; Wu H; Wang Q; Han Y; Zhou W; Li H; Wang Z
Clin Lung Cancer; 2018 May; 19(3):221-229. PubMed ID: 29275041
[TBL] [Abstract][Full Text] [Related]
6. Elevated tumor-to-liver uptake ratio (TLR) from
Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
[TBL] [Abstract][Full Text] [Related]
7. Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors.
Kang YK; Song YS; Cho S; Jheon S; Lee WW; Kim K; Kim SE
Lung Cancer; 2018 May; 119():1-6. PubMed ID: 29656743
[TBL] [Abstract][Full Text] [Related]
8. Correlation between maximum standardized uptake values on FDG-PET and microenvironmental factors in patients with clinical stage IA radiologic pure-solid lung adenocarcinoma.
Ichikawa T; Aokage K; Miyoshi T; Tane K; Suzuki K; Makinoshima H; Tsuboi M; Ishii G
Lung Cancer; 2019 Oct; 136():57-64. PubMed ID: 31445355
[TBL] [Abstract][Full Text] [Related]
9. Combination of FDG-PET and UCSF Criteria for Predicting HCC Recurrence After Living Donor Liver Transplantation.
Hsu CC; Chen CL; Wang CC; Lin CC; Yong CC; Wang SH; Liu YW; Lin TL; Lee WF; Lin YH; Chan YC; Wu YJ; Eng HL; Cheng YF
Transplantation; 2016 Sep; 100(9):1925-32. PubMed ID: 27306534
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography-derived metabolic parameters in surgically resected clinical-N0 nonsmall cell lung cancer.
Aktas GE; Karamustafaoğlu YA; Balta C; Süt N; Sarikaya İ; Sarikaya A
Nucl Med Commun; 2018 Nov; 39(11):995-1004. PubMed ID: 30188416
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of [(18)F]fluorodeoxyglucose uptake on positron emission tomography in patients with pathologic stage I lung adenocarcinoma.
Ohtsuka T; Nomori H; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Cancer; 2006 Nov; 107(10):2468-73. PubMed ID: 17036361
[TBL] [Abstract][Full Text] [Related]
12. F-18 FDG uptake on positron emission tomography as a predictor for lymphovascular invasion in patients with lung adenocarcinoma.
Noda Y; Goshima S; Kanematsu M; Watanabe H; Kawada H; Kawai N; Ono H; Bae KT
Ann Nucl Med; 2016 Jan; 30(1):11-7. PubMed ID: 26337532
[TBL] [Abstract][Full Text] [Related]
13. Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact.
Tanaka T; Shinya T; Sato S; Mitsuhashi T; Ichimura K; Soh J; Toyooka S; Kaji M; Miyoshi S; Kanazawa S
Ann Nucl Med; 2015 Nov; 29(9):757-65. PubMed ID: 26142739
[TBL] [Abstract][Full Text] [Related]
14. Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.
Higashi K; Sakuma T; Ito K; Niho S; Ueda Y; Kobayashi T; Sekiguchi R; Takahashi T; Kato T; Tonami H
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):373-81. PubMed ID: 18931837
[TBL] [Abstract][Full Text] [Related]
15. Assessment of VEGF-D expression measured by immunohistochemical staining and F-18 FDG uptake on PET as biological prognostic factors for recurrence in patients with surgically resected lung adenocarcinoma.
Zhang L; Higashi K; Ishigaki Y; Ueda Y; Sakuma T; Takegami T; Oguchi M; Xu K; Ohta Y; Nishida H; Tonami H
Ann Nucl Med; 2010 Aug; 24(7):533-40. PubMed ID: 20607627
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma.
Higuchi M; Hasegawa T; Osugi J; Suzuki H; Gotoh M
Ann Thorac Cardiovasc Surg; 2014; 20(3):185-91. PubMed ID: 23603641
[TBL] [Abstract][Full Text] [Related]
17. A clinical study of the prognostic factors for postoperative early recurrence in patients who underwent complete resection for pulmonary adenocarcinoma.
Sakai T; Tsushima T; Kimura D; Hatanaka R; Yamada Y; Fukuda I
Ann Thorac Cardiovasc Surg; 2011; 17(6):539-43. PubMed ID: 21881354
[TBL] [Abstract][Full Text] [Related]
18. Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?
Park HL; Yoo IR; Boo SH; Park SY; Park JK; Sung SW; Moon SW
J Cancer Res Clin Oncol; 2019 Apr; 145(4):1021-1026. PubMed ID: 30756189
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of 18F-FDG uptake on PET in non-small cell lung cancer patients with postoperative recurrence following platinum-based chemotherapy.
Kaira K; Yamamoto N; Kenmotsu H; Murakami H; Ono A; Naito T; Endo M; Takahashi T
Respir Investig; 2014 Mar; 52(2):121-8. PubMed ID: 24636268
[TBL] [Abstract][Full Text] [Related]
20. PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer.
Nair VS; Barnett PG; Ananth L; Gould MK;
Chest; 2010 May; 137(5):1150-6. PubMed ID: 20038738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
